- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02807688
Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses (PHYSICO-DSM-VR)
PHYSICO-DSM-VR - Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses: a Prevalence Study and a Randomised Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Epidemiological studies investigating the mortality and physical health of mental patients have provided substantial evidence of an excess mortality and of a substantially higher prevalence of physical co-morbidity as compared to the general population. These findings have been related to a higher prevalence of risk factors like high blood pressure, high plasma cholesterol and obesity, unhealthy lifestyles, medication side-effects.
The number of clinical trials and intervention studies in this area is still scanty and their scientific strength is relatively modest. The present research project aims at implementing preventive strategies related to dietary habits and physical exercise, and studying their efficacy with a randomized controlled study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Verona, Italy, 37126
- UOC 1° Servizio Psichiatria - ULSS 20
-
Verona, Italy, 37126
- UOC 2° Servizio Psichiatria - ULSS 20
-
Verona, Italy, 37134
- UOC 3° Servizio Psichiatria - ULSS 20
-
-
Verona
-
San Bonifacio, Verona, Italy, 37047
- UOC 4° Servizio Psichiatria - ULSS 20
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ICD-10 diagnosis of affective or non-affective functional psychosis (codes F20-22, F24, F25, F28-F31, F23.3, F33.3)
- one or more contacts with the CMHS in the 3 months preceding the beginning of the recruitment
- Age 18-65
Exclusion Criteria:
- moderate or severe mental handicap (learning disability)
- organic brain disorders
- lack of capacity to consent to inclusion
- subjects already involved in individual treatment related to diet and physical exercise
- subjects deemed unable or unfit to participate in the proposed physical activities
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention
"Health Promotion Intervention" package including elements of psychoeducation on healthy lifestyles and practical sessions of physical activity, with the use of motivational techniques.
|
The intervention package consists of the following elements: i. educational sessions on the importance of diet and fitness; ii. motivational interviews to maintain participants in the program, to discuss participants' physical conditions, habits and opinions as to diet and fitness; iii. monitoring the participation in the program and health behaviour, specifically for diet and fitness, and adherence to the intervention on diet and fitness; iv. regular physical exercise under the guide and supervision of an expert trainer. |
NO_INTERVENTION: Control
Control subjects receive treatment as usual at the Community Mental Health Services of the Department of Mental Health.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the number of participants that comply with WHO recommendations on diet and/or exercise
Time Frame: baseline, month 1, month 2, month 3, month 4, month 5 and month 6
|
Following the criteria proposed by World Health Organization for a healthy lifestyle: at least 5 servings of fruit/vegetables per day and at least 30 minutes of moderate physical activity per day 5 days a week.
Achieving at least one more criterion than baseline at follow up is considered a success.
|
baseline, month 1, month 2, month 3, month 4, month 5 and month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical examination
Time Frame: baseline
|
Physical examination by psychiatrist
|
baseline
|
Long term chronic disease inventory (items 2.1-2.24; MOD.ISTAT/IMF-8/B.04-05-ISTAT)
Time Frame: baseline
|
Questionnaire assessing chronic diseases, administered by investigators
|
baseline
|
Change in blood pressure
Time Frame: baseline, month 1, month 2, month 3, month 4, month 5 and month 6
|
baseline, month 1, month 2, month 3, month 4, month 5 and month 6
|
|
Change in pulses
Time Frame: baseline, month 1, month 2, month 3, month 4, month 5 and month 6
|
baseline, month 1, month 2, month 3, month 4, month 5 and month 6
|
|
Change in Body Mass Index
Time Frame: baseline, month 1, month 2, month 3, month 4, month 5 and month 6
|
baseline, month 1, month 2, month 3, month 4, month 5 and month 6
|
|
Change in waist circumference
Time Frame: baseline, month 1, month 2, month 3, month 4, month 5 and month 6
|
baseline, month 1, month 2, month 3, month 4, month 5 and month 6
|
|
Change in glycemia
Time Frame: baseline and month 6
|
baseline and month 6
|
|
Change in haemoglobin A1C
Time Frame: baseline and month 6
|
baseline and month 6
|
|
Change in LDL cholesterol
Time Frame: baseline and month 6
|
baseline and month 6
|
|
Change in HDL cholesterol
Time Frame: baseline and month 6
|
baseline and month 6
|
|
Change in triglyceridemia
Time Frame: baseline and month 6
|
baseline and month 6
|
|
Electrocardiogram
Time Frame: baseline
|
baseline
|
|
Medication History Schedule
Time Frame: baseline
|
Ad hoc form filled in by psychiatrist on present and previous psychopharmacological or non psychopharmacological medications taken by the participant
|
baseline
|
36 Item Short Form Health Survey
Time Frame: beginning and month 6
|
beginning and month 6
|
|
Verona Service Satisfaction Scale - European Version
Time Frame: beginning and month 6
|
beginning and month 6
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lorenzo Burti, Professor, Universita di Verona
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CE 1518
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychotic Disorders
-
Medical College of WisconsinCompletedSchizophrenia | Affective Disorders | Psychotic Disorder | Psychotic Mood Disorder
-
Søren Dinesen ØstergaardCompletedAffective Disorders, PsychoticDenmark
-
Instituto de Investigación Hospital Universitario...CompletedSchizophrenia and Disorders With Psychotic Feature | Psychotic EpisodeSpain
-
VA Office of Research and DevelopmentNot yet recruitingMI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMIHomelessness | Schizophrenia Spectrum Disorders | Psychotic Mood Disorders | Psychotic Affective Disorders | Ill-Housed PersonsUnited States
-
University of MinnesotaUniversity of California, San FranciscoCompletedPsychotic Disorders | Schizophrenia | Schizoaffective Disorder | Cognitive Impairment | Psychosis | Treatment | Psychotic Depression | Psychotic Episode | Active Control | Psychotic Mood DisordersUnited States
-
Instituto de Investigación Hospital Universitario...Carlos III Health Institute; European Regional Development FundCompletedSchizophrenia and Disorders With Psychotic Features | Psychotic EpisodeSpain
-
Centre hospitalier de Ville-Evrard, FranceRecruiting
-
University Hospital, CaenRecruiting
-
University of California, San DiegoActive, not recruitingSchizophrenia | Schizoaffective Disorder | Mood Disorder, PsychoticUnited States
-
Boston Medical CenterNational Institute of Mental Health (NIMH); Beth Israel Deaconess Medical CenterCompletedPsychotic Disorders | Psychosis | Psychotic EpisodeUnited States
Clinical Trials on Health Promotion Intervention
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedSexually Transmitted Disease (STD) | Human Immunodeficiency Virus Infection (HIV)United States
-
Yonsei UniversityCompletedWomen Who Have Experienced TraumaKorea, Republic of
-
University of OsloTechnical University of Munich; National Institute for Medical Research, Tanzania and other collaboratorsCompletedHIV Infections | Tuberculosis | Cysticercosis | Tapeworm PorkTanzania
-
California Polytechnic State University-San Luis...Brown UniversityCompletedGestational Diabetes MellitusUnited States
-
KU LeuvenVLIR-UOS; Kyambogo University; Our Lady of Africa Mbuya Catholic ParishCompleted
-
Columbia UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingBlood PressureUnited States
-
Emory UniversityCenters for Disease Control and PreventionCompletedHIV InfectionsUnited States
-
University of Alabama at BirminghamCompletedGlaucomaUnited States
-
Instituto Mexicano del Seguro SocialUniversity of California, Los Angeles; National Council of Science and Technology...CompletedCardiovascular Risk FactorsMexico
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Ontario Ministry of Health and...CompletedDepressive SymptomsCanada